Mölnlycke joins AstraZeneca BioVentureHub
Photographer: Jenny JohanssonAstraZeneca's CEO Sweden, Jan-Olof Jacke, signs the agreement with Mölnlycke's Executive Vice President for R&D, Barry McBride on 1 June 2017
Mölnlycke is a world-leading medical solutions company. We design and supply solutions to enhance performance at every point of care – from the hospital to the home. We specialise in solutions for managing wounds, improving surgical safety and efficiency, and preventing pressure ulcers. Our products are available in approximately 100 countries worldwide. Mölnlycke was founded in 1849. Our headquarters are in Gothenburg, Sweden and we employ around 7,500 people. Since 2007, we belong to Investor AB, the leading owner of Nordic-based international companies.